According to a new market research report published by sheer analytics and insights, “The Global Peri-Implantitis Market was valued at $0.75 Billion in 2020, Growing at a high CAGR of more than 8.8% between 2021 and 2031, it is estimated to reach $1.9 Billion by 2031, as per the latest market research report titled Global Peri-Implantitis Market - industry analysis, size, share, growth, trends, and forecast, 2021-2031.
Peri-implantitis is a site-specific infectious disease. The disease affects soft tissues and causes bone loss around an Osseointegrated implant in function. Nowadays, the Osseointegrated dental implant process has become a very popular modality of treatment to replace absent or lost teeth. Dental implants have high long-term survival rates (greater than ten years) when used to support various types of dental prostheses. However, dental implants' long-term success is not the same or as high as their survival. Their restorations may be subject to biological and mechanical complications. The increasing demand for dental implants for many dental treatments like peri-implant mucositis and peri-implantitis is boosting the market growth. The increasing aging population and rising awareness for dental health are the prime factors that drive market growth during the forecast period.
However, in this current pandemic of COVID-19, the Peri-Implantitis market was affected much. It changes the growth rate graph slightly in the Peri-Implantitis market. But it has been expected that after the pandemic situation, the global Peri-Implantitis market will reach a high position in the graph. Apart from that, the rising of the dental sector across the world is anticipated to offer a massive opportunity for market growth in the next forecast period of 2021 to 2031.
Geographically, The Peri-Implantitis Market is divided into global regions like North America, Europe, Asia- Pacific, Latin America, Middle East, and Africa.
The report covers a detailed outlook about the company, and it includes the company or industry profiles and market share of key players operating in the global market. Key players in the report include Triveni chemicals, Pfizer Inc.; Cadila Pharmaceuticals; R.N. Laboratories Pvt. Ltd.; Basic Pharma Life Science Pvt. Ltd.; Prachi Pharmaceuticals Private Limited., Geistlich Pharma Inc.; and Healthy Life Pharma among others.
The Global Peri-Implantitis Market Has Been Segmented into:
Global Peri-Implantitis Market: By Method Type
Global Peri-Implantitis Market: By End-User
Global Peri-Implantitis Market: By Region